CompletedPhase 2NCT02276898

A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Hospital for Sick Children
Principal Investigator
Reshma Amin, MD
The Hospital for Sick Children
Intervention
Hypertonic Saline 7%(drug)
Enrollment
24 enrolled
Eligibility
6-18 years · All sexes
Timeline
20112014

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02276898 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials